The Short Form-6 Dimension (SF-6D) Validity and Reliability in Hemodialysis Patients
Downloads
Andayani, T. M., Kristina, S. A., Endarti, D., Haris, R. N. H. & Rahmawati, A., 2020. Translation, Cultural Adaptation, and Validation of Short-Form 6D on the General Population in Indonesia. Value in Health Regional Issues; 21; 205–210.
Agency for Health Research and Development (Badan Penelitian dan Pengembangan Kesehatan). (2019). Laporan Nasional RISKESDAS 2018. Jakarta: Lembaga Penerbit Badan Penelitian dan Pengembangan Kesehatan.
Brazier, J., Roberts, J. & Deverill, M. (2002). The Estimation of a Preference-Based Measure of Health from the SF-36. Journal of Health Economics; 21; 271–292.
Cha, J. & Han, D., 2020. Health-Related Quality of Life Based on Comorbidities Among Patients with End-Stage Renal Disease. Osong Public Health and Research Perspectives; 11; 194–200.
Collister, D., Komenda, P., Hiebert, B., Gunasekara, R., Xu, Y., Eng, F., Lerner, B., Macdonald, K., Rigatto, C. & Tangri, N. (2016). The Effect of Erythropoietin-Stimulating Agents on Health-Related Quality of Life in Anemia of Chronic Kidney Disease: A Systematic Review and Meta-analysis. Annals of Internal Medicine; 164; 472–478.
Halbesma, N., Brantsma, A. H., Bakker, S. J. L., Jansen, D. F., Stolk, R. P., De Zeeuw, D., Jong, P. E. D. & Gansevoort, R. T. (2008). Gender Differences in Predictors of the Decline of Renal Function in the General Population. Kidney International; 74; 505–512.
Kalsoom, U. (2019). Gender Role in Anxiety, Depression and Quality of Life in Chronic Kidney Disease Patients. Pakistan Journal of Medical Sciences; 36; 251–254.
Kularatna, S., Senanayake, S., Gunawardena, N. & Graves, N. (2019). Comparison of the EQ-5D 3L and the SF-6D (SF-36) Contemporaneous Utility Scores in Patients with Chronic Kidney Disease in Sri Lanka: a Cross-Sectional Survey. BMJ Open; 9; e024854.
Pan, C.-W., Wu, Y., Zhou, H.-J., Xu, B.-X., dan Wang, P., 2018. Health-Related Quality of Life and Its Factors of Hemodialysis Patients in Suzhou, China. Blood Purification; 45; 327–333.
Poder, T. G. & Gandji, E.W. (2016). SF6D Value Sets: a Systematic Review. Value in Health; 19; A282.
Sihombing, J. P. (2019). Cost-Effectiveness Analysis Eritropoetin Alfa Dibandingkan Dengan Eritropoetin Beta Pada Pengobatan Anemia Pasien Penyakit Ginjal Kronik Yang Menjalani Hemodialisis Rutin. Disertasi; Fakultas Farmasi Universitas Gadjah Mada, Yogyakarta.
Thaweethamcharoen, T., Noparatayaporn, P., Sritippayawan, S. & Aiyasanon, N. (2019). Comparison of EQ-5D-5L, VAS, and SF-6D in Thai Patients on Peritoneal Dialysis. Value in Health Regional Issues; 18; 59–64.
Wyld, M. L. R., Chadban, S. J. & Morton, R. L. (2016). Improving Our Understanding of Quality of Life in CKD. American Journal of Kidney Diseases; 67; 820–821.
Yang, F., Lau, T., Lee, E., Vathsala, A., Chia, K. S. & Luo, N. (2015). Comparison of the Preference-Based EQ-5D-5L and SF-6D in Patients with End-Stage Renal Disease (ESRD). The European Journal of Health Economics; 16; 1019–1026.
1. The copyright of this journal belongs to the Editorial Board and Journal Manager with the author's knowledge, while the moral right of the publication belong to the author.
2. The formal legal aspect of journal publication accessibility refers to the Creative Commons Attribution-Non-Commercial-Share Alike (CC BY-NC-SA), which implies that the publication can be used for non-commercial purposes in its original form.
3. Every publication (print/electronic) is open access for educational, research, and library purposes. In addition to the objectives mentioned above, the editorial board is not responsible for copyright infringement